[Chronic toxicity study on difluprednate in dogs]

Area of Science:

• Dermatology
• Toxicology
• Pharmacology

Context:

• Topical glucocorticoids are widely used for inflammatory skin conditions.
• Understanding the chronic toxicity profile of new glucocorticoids is crucial for safety assessment.

Purpose:

• To evaluate the chronic toxicity of difluprednate (DFBA) ointment in Beagle dogs following repeated topical application.
• To determine dose-dependent local and systemic effects and identify a potential no-observed-adverse-effect level (NOAEL).

Summary:

• Percutaneous application of DFBA ointment (0.05%) at 125, 12.5, and 1.25 µg/kg/day for 6 months induced dose-dependent local effects (skin thinning, fur growth inhibition) and systemic effects (hematological, biochemical, organ weight changes, pathological findings) in Beagle dogs.
• Systemic effects, including thymus and adrenal atrophy, were observed at the highest dose (125 µg/kg/day).
• The 12.5 µg/kg/day dose showed slight atrophic changes, while 1.25 µg/kg/day resulted in no observed changes, suggesting 12.5 µg/kg/day is near the NOAEL.

Impact:

• The study confirms that observed local and systemic changes are consistent with the known pharmacological effects of glucocorticoids.
• A dosage of 12.5 µg/kg/day is considered a non-effect dose, providing valuable safety data for difluprednate's topical use.